GLPBio

Apoptosis

Read More about this category

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

 

References:

1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.

2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.

3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.

4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.

5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Research Areas

Products Related to Apoptosis(3030)

  • GN10394 structure
    GN10394Atractylenolide III
    CAS: 73030-71-4
    Purity: >98.00%
  • GN10405 structure
    GN10405Loganin
    CAS: 18524-94-2
    Purity: >98.00%
  • GN10415 structure
    GN10415Astilbin
    CAS: 29838-67-3
    Purity: >97.00%
  • GN10421 structure
    GN10421Kaempferol
    CAS: 520-18-3
    Purity: >98.50%

    ケンペロール(Kaempferol)はフラボノイドであり、ERRαとERRγの逆作動薬であり、抗酸化、抗炎症と抗腫瘍活性を持つ。

  • GN10429 structure
    GN10429Neochlorogenic acid
    CAS: 906-33-2
    Purity: >98.00%
  • GN10451 structure
    GN10451Psoralen
    CAS: 66-97-7
    Purity: >99.50%
  • GN10453 structure
    GN10453Ginkgolide B
    CAS: 15291-77-7
    Purity: >98.00%

    Ginkgolide Bはイチョウの葉から抽出されたテルペンラクトンであり、血小板活性化因子(PAF)の特異性の拮抗剤であり、IC 50 は3.6μMである。

  • GN10456 structure
    GN10456L-Theanine
    CAS: 3081-61-6
    Purity: >99.50%

    L-Theanine is a natural non-protein amino acid with neuroprotective and anti-inflammatory effects.

  • GN10457 structure
    GN10457Oleuropein
    CAS: 32619-42-4
    Purity: >98.00%

    Oleuropeinはオリーブの木の主なフェノール化合物であり、強力な抗酸化と抗炎症特性を持っている。

  • GN10462 structure
    GN10462Pulsatilla saponin D
    CAS: 68027-15-6
    Purity: >98.00%
  • GN10463 structure
    GN10463Chelerythrine
    CAS: 34316-15-9
    Purity: >98%
  • GN10470 structure
    GN10470Eriodictyol
    CAS: 552-58-9
    Purity: >99.50%
  • GN10484 structure
    GN10484Amentoflavone
    CAS: 1617-53-4
    Purity: >98.00%

    Amentoflavone is an orally active phenolic compound with anti-inflammatory, anti-oxidation, anti-microbial, and anti-cancer activities.

  • GN10491 structure
    GN10491Mangiferin
    CAS: 4773-96-0
    Purity: >99.50%
  • GN10503 structure
    GN10503Piceatannol
    CAS: 10083-24-6
    Purity: >98.00%

    Piceatannol (3,3′,4,5′-トランス-トリヒドロキシスチルベン)は天然に存在するレスベラトロールのヒドロキシル化類似物である。

  • GN10504 structure
    GN10504Echinocystic acid
    CAS: 510-30-5
    Purity: >98.00%
  • GN10506 structure
    GN10506Umbelliferone
    CAS: 93-35-6
    Purity: >99.50%
  • GN10507 structure
    GN10507Baohuoside I
    CAS: 113558-15-9
    Purity: >98.00%

    Baohuoside IはEpimedium koreanumから分離されたフラボノイドであり、CXCR4の阻害剤として作用し、CXCR4の発見を下方修正し、アポトーシスを誘発し、抗腫瘍活性を示す。

  • GN10520 structure
    GN10520Benzoylpaeoniflorin
    CAS: 38642-49-8
    Purity: >98.00%
  • GN10521 structure
    GN10521Curcumol
    CAS: 4871-97-0
    Purity: >99.00%
  • GN10527 structure
    GN10527Formononetin
    CAS: 485-72-3
    Purity: >99.50%

    ホルモノネチン(Formononetin)は強力なFGFR2阻害剤であり、IC 50 値は4.3μMである。ホルモノネチンは血管新生と腫瘍の成長を強力的に阻害する。

  • GN10529 structure
    GN10529Demethoxycurcumin
    CAS: 22608-11-3;24939-17-1
    Purity: >99.00%
  • GN10531 structure
    GN10531Dimethylfraxetin
    CAS: 6035-49-0
    Purity: >99.50%
  • GN10534 structure
    GN10534Asiaticoside
    CAS: 16830-15-2
    Purity: >98.00%

    AsiaticosideはCentella asiaticaから抽出された五環式トリテルペノイド配糖体である。